Table 3

Crude and age-standardised (with the 2005 Korean census and world standard populations as references) prevalence rates (%) for specific health problems in the health screening database of the National Health Insurance Service-National Health Screening Cohort database at baseline, 2002–2003

AllMenWomen
Cohort nCrude ratesAge-standardised ratesCohort nCrude ratesAge-standardised ratesCohort nCrude ratesAge-standardised rates
CensusWHOCensusWHOCensusWHO
Anaemia*514 2569.29.89.8278 8664.45.65.9235 39015.615.915.5
Diabetes mellitus514 1907.98.28.4278 8269.09.49.6235 3646.26.46.6
Prediabetes†23.923.823.926.025.925.920.820.720.9
Hypertension514 58134.435.636.1278 98938.039.139.4235 59229.830.331.0
High-normal‡17.016.916.817.817.817.815.715.515.6
Abnormal liver function test§514 2866.25.85.8278 8665.75.35.1235 4206.56.36.4
Obesity514 3502.92.72.7278 9012.11.91.9235 4493.73.63.6
Overweight¶32.131.231.033.131.431.030.629.830.1
Hypercholesterolaemia**513 88714.314.214.3278 68113.012.512.4235 20615.815.616.0
Abnormal urine blood††513 0465.96.06.1278 2283.23.43.4234 8189.39.39.4
Abnormal urine protein‡‡513 0952.02.02.0278 2521.92.02.0234 8431.92.02.0
  • *Hb <13 g/dL (men), <12 g/dL (women).

  • †Diabetes mellitus: fasting glucose of 126 mg/dL; prediabetes, 100–126 mg/dL.

  • ‡Hypertension: systolic blood pressure of 140 mm Hg or diastolic blood pressure of 90 mm Hg; high-normal, systolic blood pressure of 130 mm Hg or diastolic blood pressure of 85 mm Hg.

  • §More than two times than upper limit of normal (ULN); ULN for alanine aminotransferase: men, 30 IU/L; women, 19 IU/L.

  • ¶Obesity: body mass index ≥30 kg/m2; overweight: body mass index 25–29.9 kg/m2.

  • **Total cholesterol ≥240 mg/dL (6.2 mmol/L).

  • ††Urine dip-stick test for occult blood: +1, +2, +3, +4.

  • ‡‡Urine dip-stick test for protein: +1, +2, +3, +4.